Jien-Wei Liu

1.3k citations
29 papers · 874 indexed · h-index 18
Topics
Antibiotic Resistance in Bacteria (8 papers)COVID-19 Clinical Research Studies (8 papers)SARS-CoV-2 and COVID-19 Research (6 papers)

In The Last Decade

Jien-Wei Liu

29 papers receiving 848 citations

Peers

Jien-Wei Liu
Comparison fields: 5 of 87
  • Infectious Diseases 315
  • Epidemiology 244
  • Public Health, Environmental and Occupational Health 195
  • Endocrinology 190
  • Molecular Medicine 135
Replace Geoffrey Kwenda with:
Geoffrey Kwenda Zambia
Oh‐Hyun Cho South Korea
Chun-Ming Lee Taiwan
Uh Jin Kim South Korea
Thuan Tong Tan Singapore
Mustafa Sünbül Türkiye
Audrey Mérens France
Hélio Caiaffa-Filho Brazil
Donald J. Lyon Hong Kong
Robert C. Kimbrough United States
Jien-Wei Liu relative to Geoffrey Kwenda Zambia Geoffrey Kwenda's profile →
Citations per field
00.5×3.8×
Geoffrey Kwenda · 1×
Citations per year

Countries citing papers authored by Jien-Wei Liu

Since Specialization
Citations

This map shows the geographic impact of Jien-Wei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jien-Wei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jien-Wei Liu more than expected).

Fields of papers citing papers by Jien-Wei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jien-Wei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jien-Wei Liu. The network helps show where Jien-Wei Liu may publish in the future.

Co-authorship network of co-authors of Jien-Wei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jien-Wei Liu. A scholar is included among the top collaborators of Jien-Wei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jien-Wei Liu. Jien-Wei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 13
3 23
4 27
5 11
6 7
7 7
8 75
9 92
10 12
11 4
12 17
13 19
14 24
15 77
16 44
17 62
18 27
19 23
20 2

About Jien-Wei Liu

Jien-Wei Liu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 29 papers that have together received 874 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Endocrinology (190 citations), Molecular Medicine (135 citations) and Applied Microbiology and Biotechnology (48 citations). Jien-Wei Liu has collaborated with scholars based in Taiwan, United States and France. Frequent co-authors include Yin-Ching Chuang, Kuender D. Yang, Po‐Ren Hsueh, Hung-Jen Tang, Wen‐Chien Ko, Hsin–Chun Lee, Meng-Chih Lin, Hock-Liew Eng, Yung-Ching Liu and Chun‐Hsing Liao. Their work appears in journals such as The Lancet, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026